Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Greenwich Lifesciences Inc (GLSI)

Greenwich Lifesciences Inc (GLSI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Greenwich Lifesciences Inc 3992 BLUEBONNET DR BUILDING 14 STAFFORD TX 77477 USA

www.cineverse.com Employees: 8 P: 832-819-3232

Sector:

Medical

Description:

Greenwich LifeSciences Inc. is a clinical stage biopharmaceutical company focuses on the development of cancer immunotherapies for breast cancer and other human epidermal growth factor. The company's product candidate includes GP2, which is in clinical stage. Greenwich LifeSciences Inc.is based in Stafford, Texas.

Key Statistics

Overview:

Market Capitalization, $K 349,007
Enterprise Value, $K 344,917
Shares Outstanding, K 13,855
Float, K 6,724
% Float 48.53%
Short Interest, K 1,546
Short Float 11.17%
Days to Cover 3.41
Short Volume Ratio 0.67
% of Insider Shareholders 51.47%
% of Institutional Shareholders 4.16%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -15,790 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -4,150 K
EBIT, $ -19,580 K
EBITDA, $ -19,580 K

Growth:

1-Year Return 132.19%
3-Year Return 53.93%
5-Year Return -25.72%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.30 on 11/14/25
Next Earnings Date 04/21/26
Earnings Per Share ttm -1.46
EPS Growth vs. Prev Qtr 0.00%
EPS Growth vs. Prev Year -50.00%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

GLSI Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -1,042.84%
Return-on-Assets % -565.44%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 171.26
Book Value/Share 0.16
Interest Coverage -4.16
60-Month Beta 1.48
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar